跳至主要内容
临床试验/ACTRN12621000707864
ACTRN12621000707864尚未招募未知

Xylitol and sodium hyaluronate nasal spray to improve postoperative healing in patients with chronic rhinosinusitis undergoing functional endoscopic sinus surgery.

Richard Douglas0 个研究点目标入组 51 人开始时间: 2021年6月8日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
51

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Chronic rhinosinusitis patients undergoing FESS due to CRS as defined by the 2020 European Position Paper on Rhinosinusitis and Nasal Polyps
  • -18 years or older
  • -Competent to give informed consent

排除标准

  • -Patients with septal perforation
  • -Pre or postoperative severe septal deviation. If a septal deviation is present, it will not be easy to discern if nasal obstruction is due to a deviated septum or to another cause such as crusting or inflammation.
  • -Patients who have had previous FESS. Patients with recalcitrant sinus disease who need another surgery usually have a greater compromise of normal nasal physiology, reducing effectiveness of topical therapies.
  • -Patients with other underlying disease that affects respiratory mucosa such as cystic fibrosis, primary ciliary dyskinesia, or aspirin hypersensitivity
  • -Any known allergies or hypersensitivity to any of the components of the formulations.

研究者

发起方
Richard Douglas

相似试验